XML 10 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 2,763,000 $ 2,983,000
General and administrative 2,213,000 2,245,000
Total operating expenses 4,976,000 5,228,000
Operating loss (3,299,000) (4,722,000)
Other income (expense):    
Interest income 72,000 51,000
Interest expense (34,000) (134,000)
Total other expense 38,000 (83,000)
Net loss $ (3,261,000) $ (4,805,000)
Net loss per share, basic $ (0.75) $ (2.07)
Net loss per share, diluted $ (0.75) $ (2.07)
Basic weighted average shares used in calculating net loss per share attributable to common stockholders 4,321,731 2,320,017
Diluted weighted average shares used in calculating net loss per share attributable to common stockholders 4,321,731 2,320,017
Grant [Member]    
Revenue $ 1,677,000 $ 506,000